Arani Leila S, Gharavi Mohammad H, Zadeh Mahdi Z, Raynor William Y, Seraj Siavash M, Constantinescu Caius M, Gerke Oke, Werner Thomas J, Høilund-Carlsen Poul F, Alavi Abass
Department of Radiology, Perelman School of Medicine, University of Pennsylvania, PA, USA.
Hell J Nucl Med. 2019 Jan-Apr;22(1):14-19. doi: 10.1967/s002449910954. Epub 2019 Mar 7.
We aimed to assess the feasibility of quantifying fluorine-18-fluorodexoglucose (F-FDG) and F-sodium fluoride (F-NaF) uptake in abdominal aorta and examine their association with age and cardiovascular risk factors.
Our study comprised 123 subjects (48±14 years of age, 62 men) including 78 healthy volunteers and 45 patients with chest pain syndrome, who originally enrolled in the CAMONA study in Odense, Denmark (NCT01724749). All subjects underwent F-FDG positron emission tomography/computed tomography (PET/CT) and F-NaF PET/CT on separate days, 180min and 90min after administration of tracers, respectively. The global tracer uptake value (GTUV) in the abdominal aorta was determined as sum of the product of each slice area and its corresponding average standardized uptake value (SUV mean), divided by the sum of those slice areas. In addition, for each subject, the 10 years Framingham risk score (FRS) was calculated. The correlations between F-NaF and F-FDG GTUV with age and 10 years FRS were assessed in all, healthy and patient subjects.
There was a significant, positive correlation between subjects' age and F-NaF GTUV (r=0.35, P<0.001), but not F-FDG GTUV (r=0.06, P=0.53). Also, there was a significant, positive correlation between 10 years FRS and F-NaF GTUV (r=0.30, P<0.001), but not F-FDG GTUV (r=0.01, P=0.95). Individual differences in F-FDG and 1F-NaF uptake were large in both healthy subjects and patients.
In this study, the global uptake of F-NaF in abdominal aorta was positively associated with age and 10 years FRS in all subjects, healthy and patient groups, whereas the global uptake of F-FDG was not.
我们旨在评估定量分析腹主动脉中氟-18-氟脱氧葡萄糖(F-FDG)和氟-氟化钠(F-NaF)摄取情况的可行性,并研究它们与年龄及心血管危险因素之间的关联。
我们的研究纳入了123名受试者(年龄48±14岁,男性62名),其中包括78名健康志愿者和45名胸痛综合征患者,这些受试者最初参与了丹麦欧登塞的CAMONA研究(NCT01724749)。所有受试者分别在不同日期接受F-FDG正电子发射断层扫描/计算机断层扫描(PET/CT)和F-NaF PET/CT检查,分别在注射示踪剂后180分钟和90分钟进行。腹主动脉的整体示踪剂摄取值(GTUV)通过将每个切片面积与其相应的平均标准化摄取值(SUV均值)的乘积之和除以这些切片面积之和来确定。此外,为每个受试者计算10年弗明汉风险评分(FRS)。在所有受试者、健康受试者和患者中评估F-NaF和F-FDG GTUV与年龄及10年FRS之间的相关性。
受试者年龄与F-NaF GTUV之间存在显著正相关(r = 0.35,P < 0.001),但与F-FDG GTUV无相关性(r = 0.06,P = 0.53)。同样,10年FRS与F-NaF GTUV之间存在显著正相关(r = 0.30,P < 0.001),但与F-FDG GTUV无相关性(r = 0.01,P = 0.95)。健康受试者和患者中F-FDG和F-NaF摄取的个体差异都很大。
在本研究中,腹主动脉中F-NaF的整体摄取在所有受试者、健康组和患者组中均与年龄及10年FRS呈正相关,而F-FDG的整体摄取则不然。